Current Report

 

 

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) of

the SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of earliest event reported): May 23, 2013

 

 

ATRICURE, INC.

(Exact name of registrant as specified in charter)

 

 

 

Delaware   000-51470   34-1940305

(State or other jurisdiction

of incorporation)

 

(Commission

File Number)

 

(IRS Employer

Identification No.)

 

6217 Centre Park Drive

West Chester, OH

  45069
(Address of principal executive offices)   (Zip Code)

Registrant’s telephone number, including area code: (513) 755-4100

Not Applicable

(Former name or former address, if changed since last report)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 


Item 5.07. Submission of Matters to a Vote of Security Holders.

The stockholders of AtriCure, Inc. (the “Company”) voted on four items at the Annual Meeting of Stockholders held on May 23, 2013:

 

  1. The election of nine directors to serve one-year terms expiring at the 2014 Annual Meeting and until their successors have been duly elected and qualified;

 

  2. A proposal to ratify the appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2013;

 

  3. An advisory vote on the compensation of the Company’s named executive officers as disclosed in the proxy statement; and

 

  4. An advisory vote on the frequency for future advisory votes on executive compensation.

The nominees for director were elected based upon the following votes:

 

Director Nominees

   Votes For      Votes Withheld      Broker Non-Votes  

Michael H. Carrel

     13,024,270         215,384         5,392,853   

Mark A. Collar

     12,915,262         324,392         5,392,853   

Donald C. Harrison, M.D.

     12,750,741         488,913         5,392,853   

Michael D. Hooven

     12,227,101         1,012,553         5,392,853   

Richard M. Johnston

     12,759,293         480,361         5,392,853   

Elizabeth D. Krell, Ph.D.

     12,126,652         1,113,002         5,392,853   

Mark R. Lanning, C.P.A.

     12,918,393         321,261         5,392,853   

Karen P. Robards

     12,932,116         307,538         5,392,853   

Robert S. White

     13,030,661         209,993         5,392,853   

The proposal to ratify the appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2013 received the following votes:

 

For:

     18,390,630   

Against:

     240,077   

Abstain:

     800   

Broker Non-Votes:

     1,000   

The advisory vote on the compensation of the Company’s named executive officers as disclosed in the proxy statement received the following votes:

 

For:

     9,424,579   

Against:

     3,766,700   

Abstain:

     48,375   

Broker Non-Votes:

     5,392,853   

The advisory vote on the frequency for future advisory votes on executive compensation received the following votes:

 

Every Year:

     11,855,494   

Every Two Years:

     463,500   

Every Three Years:

     623,577   

Abstain:

     9,210   

Broker Non-Votes:

     5,680,726   

In light of the voting results with respect to the frequency of future shareholder votes on executive compensation, the Company’s Board of Directors has determined that the Company will hold an annual advisory vote on the compensation of named executive officers. The Company is required to hold an advisory vote on frequency at a minimum of every six years.


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

    ATRICURE, INC.
Date: May 24, 2013     By:   /s/ M. Andrew Wade
      M. Andrew Wade
      Vice President and Chief Financial Officer